Home
  • E-mailsverre.sandberg@uib.no
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2024). The European biological variation study (EuBIVAS): Biological variation data for testosterone, follicle stimulating hormone, prolactin, luteinizing hormone and dehydroepiandrosterone sulfate in men. Clinica Chimica Acta.
  • Show author(s) (2024). High prevalence of retinopathy in young-onset type 2 diabetes and possible sex differences: insights from Norwegian general practice. BMJ Open Diabetes Research & Care.
  • Show author(s) (2022). Using three external quality assurance schemes to achieve equivalent international normalized ratio results in primary and secondary healthcare. Clinical Chemistry and Laboratory Medicine. 419-426.
  • Show author(s) (2022). Porphyria cutanea tarda and patterns of long-term sick leave and disability pension: a 24-year nationwide matched-cohort study. Orphanet Journal of Rare Diseases. 1-12.
  • Show author(s) (2022). Point-of-care testing in primary healthcare: a scoring system to determine the frequency of performing internal quality control. Clinical Chemistry and Laboratory Medicine. 740-747.
  • Show author(s) (2022). Lot-to-lot reagent verification: Challenges and possible solutions. Clinical Chemistry and Laboratory Medicine.
  • Show author(s) (2022). Level of education is associated with coronary heart disease and chronic kidney disease in individuals with type 2 diabetes: a population-based study. BMJ Open Diabetes Research & Care.
  • Show author(s) (2022). Fur glowing under ultraviolet: in situ analysis of porphyrin accumulation in the skin appendages of mammals. Integrative Zoology.
  • Show author(s) (2022). Fear of Covid 19 during the third wave of infection in Norwegian patients with type 1 diabetes. PLOS ONE. 1-13.
  • Show author(s) (2022). Differences between Educational and Regulatory External Quality Assurance/Proficiency Testing Schemes. Clinical Chemistry. 1238-1244.
  • Show author(s) (2020). Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2. Clinical Chemistry and Laboratory Medicine. 1595-1600.
  • Show author(s) (2020). Critical appraisal and meta-Analysis of biological variation studies on glycosylated albumin, glucose and HbA<inf>1c</inf>. Advances in laboratory medicine.
  • Show author(s) (2019). Setting clinical performance specifications to develop and evaluate biomarkers for clinical use. Annals of Clinical Biochemistry. 1-9.
  • Show author(s) (2019). Quality of warfarin therapy and quality of life are improved by self-management for two years. Thrombosis and Haemostasis. 1632-1641.
  • Show author(s) (2019). Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM). Clinical Chemistry and Laboratory Medicine. 1511-1521.
  • Show author(s) (2019). Commutability of a whole-blood external quality assessment material for point-of-care C-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 791-797.
  • Show author(s) (2019). A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria. Molecular Therapy.
  • Show author(s) (2018). Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects. Clinical Chemistry and Laboratory Medicine. 1309-1318.
  • Show author(s) (2018). The EuBIVAS: Within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin, and glucose. Clinical Chemistry. 1380-1393.
  • Show author(s) (2018). Practical guide for identifying unmet clinical needs for biomarkers. Electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (eJIFCC). 129-137.
  • Show author(s) (2018). Hjemmetjenesten driver omfattende laboratorievirksomhet. Sykepleien Forskning. 1-15.
  • Show author(s) (2018). Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014. Scandinavian Journal of Primary Health Care. 170-179.
  • Show author(s) (2017). Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements? Scandinavian Journal of Primary Health Care. 299-306.
  • Show author(s) (2017). Type 2 diabetes in general practice in Norway 2005-2015: moderate improvements in risk factor control, but still major gaps in complication screening. BMJ Open Diabetes Research & Care. 11 pages.
  • Show author(s) (2017). The EuBIVAS project: within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring. Clinical Chemistry. 1527-1536.
  • Show author(s) (2017). Intensive educational efforts combined with external quality assessment improve the preanalytical phase in general practitioner offices and nursing homes. Clinical Chemistry and Laboratory Medicine. 1857-1864.
  • Show author(s) (2017). Glycemic control and complications in patients with type 1 diabetes – a registry-based longitudinal study of adolescents and young adults. Pediatric Diabetes. 188-195.
  • Show author(s) (2017). Estimates of within-subject biological variation of protein c, antithrombin, protein s free, protein s activity, and activated protein c resistance in pregnant women. Clinical Chemistry. 898-907.
  • Show author(s) (2017). Biological variation: Evaluation of methods for constructing confidence intervals for estimates of within-person biological variation for different distributions of the within-person effect. Clinica Chimica Acta. 166-173.
  • Show author(s) (2017). Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum. Clinical Chemistry. 1141-1150.
  • Show author(s) (2017). Acute hepatic porphyria and cancer risk: a nationwide cohort study. Journal of Internal Medicine. 229-240.
  • Show author(s) (2017). A pragmatic approach to sample acceptance and rejection. Clinical Biochemistry. 605-611.
  • Show author(s) (2016). The variation in high sensitive cardiac troponin concentration during haemodialysis treatment is not similar to the biological variation observed in stable end stage renal disease patients. Scandinavian Journal of Clinical and Laboratory Investigation. 645-652.
  • Show author(s) (2016). The importance of reagent lot registration in external quality assurance/proficiency testing schemes. Clinical Chemistry. 708-715.
  • Show author(s) (2016). Sample collections from healthy volunteers for biological variation estimates' update: A new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine. Clinical Chemistry and Laboratory Medicine. 1599-1608.
  • Show author(s) (2016). Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries. Thrombosis Research. 1-7.
  • Show author(s) (2016). Illness perception and psychological distress in persons with porphyria cutanea tarda. Acta Dermato-Venereologica. 674-678.
  • Show author(s) (2016). Effect of participating in a quality improvement system over time for point-of-care c-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 1474-1481.
  • Show author(s) (2016). Biological variation: The effect of different distributions on estimated within-person variation and reference change values. Clinical Chemistry. 725-736.
  • Show author(s) (2015). Setting analytical performance specifications based on outcome studies - Is it possible? Clinical Chemistry and Laboratory Medicine. 841-848.
  • Show author(s) (2015). Proposal for the modification of the conventional model for establishing performance specifications. Clinical Chemistry and Laboratory Medicine. 925-937.
  • Show author(s) (2015). Point-of-care urine albumin in general practice offices: Effect of participation in an external quality assurance scheme. Clinical Chemistry and Laboratory Medicine. 45-51.
  • Show author(s) (2015). Feasibility of using self-reported patient data in a national diabetes register. BMC Health Services Research. 1-7.
  • Show author(s) (2015). Egenkontroll av warfarinbehandling. Tidsskrift for Den norske legeforening. 849-853.
  • Show author(s) (2015). Benchmarking by HbA1c in a national diabetes quality register - does measurement bias matter? Clinical Chemistry and Laboratory Medicine. 1433-1439.
  • Show author(s) (2015). Analytical performance specifications based on how clinicians use laboratory tests. Experiences from a post-analytical external quality assessment programme. Clinical Chemistry and Laboratory Medicine. 857-862.
  • Show author(s) (2015). An international study of how laboratories handle and evaluate patient samples after detecting an unexpected APTT prolongation. Clinical Chemistry and Laboratory Medicine. 1593-1603.
  • Show author(s) (2015). A skin disease, a blood disease or something in between? : an exploratory focus group study of patients' experiences with porphyria cutanea tarda. British Journal of Dermatology. 223-229.
  • Show author(s) (2015). A checklist for critical appraisal of studies of biological variation. Clinical Chemistry and Laboratory Medicine. 879-885.
  • Show author(s) (2014). Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clinical Chemistry. 838-847.
  • Show author(s) (2014). The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin. Scandinavian Journal of Clinical and Laboratory Investigation. 470-476.
  • Show author(s) (2014). Porfyrisykdommer i Norge. Tidsskrift for Den norske legeforening. 831-835.
  • Show author(s) (2014). Nursing home patients with diabetes: Prevalence, drug treatment and glycemic control. Diabetes Research and Clinical Practice. 102-109.
  • Show author(s) (2014). How to achieve harmonisation of laboratory testing -The complete picture. Clinica Chimica Acta. 8-14.
  • Show author(s) (2014). From biomarkers to medical tests: The changing landscape of test evaluation. Clinica Chimica Acta. 49-57.
  • Show author(s) (2014). From biomarkers to medical tests: The changing landscape of test evaluation. Clinica Chimica Acta. 49-57.
  • Show author(s) (2014). Albumin adsorption onto surfaces of urine collection and analysis containers. Clinica Chimica Acta. 40-45.
  • Show author(s) (2013). The Norwegian Diabetes Register for Adults –an overview of the first years. Norsk Epidemiologi. 29-34.
  • Show author(s) (2013). Heterogeneity in the handling of vitamin-K-antagonists and of INR: the example of Quercy-Rouergue. Annales de Biologie Clinique. 707-716.
  • Show author(s) (2013). External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clinical Chemistry. 363-371.
  • Show author(s) (2013). Diagnosing Diabetes Mellitus: Performance of Hemoglobin A(1c) Point-of-Care Instruments in General Practice Offices. Clinical Chemistry. 1790-1801.
  • Show author(s) (2013). Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria. Bioscience Reports. 617-U203.
  • Show author(s) (2013). Behandlingen av type 1-diabetes i spesialisthelsetjenesten – data fra Norsk diabetesregister for voksne. Tidsskrift for Den norske legeforening. 2257-2261.
  • Show author(s) (2013). A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase. Clinical Chemistry and Laboratory Medicine. 1997-2007.
  • Show author(s) (2012). Regional differences in sales of glucometer strips and antidiabetics. Tidsskrift for Den norske legeforening. 1453-1456.
  • Show author(s) (2012). Preanalytical quality improvement: in quality we trust. Clinical Chemistry and Laboratory Medicine.
  • Show author(s) (2012). Interpretation and management of INR results: A case history based survey in 13 countries. Thrombosis Research. 309-315.
  • Show author(s) (2012). Increased yet iron-restricted erythropoiesis in postpartum mothers. Annals of Hematology. 1435-1441.
  • Show author(s) (2012). How do laboratory specialists advise clinicians concerning the use and interpretation of renal tests? Scandinavian Journal of Clinical and Laboratory Investigation. 143-151.
  • Show author(s) (2012). External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe. Clinical Chemistry and Laboratory Medicine. 81-88.
  • Show author(s) (2012). Establishing a network of specialist Porphyria centres - effects on diagnostic activities and services. Orphanet Journal of Rare Diseases. 9 pages.
  • Show author(s) (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. Clinical Chemistry and Laboratory Medicine. 1611-1620.
  • Show author(s) (2012). Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals. Clinical Chemistry. 1306-1313.
  • Show author(s) (2012). A model for calculating the within-subject biological variation and likelihood ratios for analytes with a time-dependent change in concentrations; exemplified with the use of D-dimer in suspected venous thromboembolism in healthy pregnant women. Annals of Clinical Biochemistry. 561-569.
  • Show author(s) (2011). Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. Clinical Chemistry and Laboratory Medicine. 1501-1507.
  • Show author(s) (2011). Standardisert hemoglobin A1C til diagnostisk bruk? Tidsskrift for Den norske legeforening. 565-6.
  • Show author(s) (2011). Quality assurance of laboratory work and clinical use of laboratory tests in general practice in Norway: A survey. Scandinavian Journal of Primary Health Care. 171-175.
  • Show author(s) (2011). Preanalytical quality improvement: from dream to reality. Clinical Chemistry and Laboratory Medicine. 1113-1126.
  • Show author(s) (2011). Laboratory investigation and follow-up of chronic kidney disease stage 3 in primary care. Clinica Chimica Acta. 1138-1142.
  • Show author(s) (2011). European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. Clinical Chemistry. 1514-1523.
  • Show author(s) (2011). Effect of ambient temperature on analytical performance of self-monitoring blood glucose systems. Diabetes Technology & Therapeutics. 883-892.
  • Show author(s) (2011). Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus? Clinical Chemistry and Laboratory Medicine. 637-640.
  • Show author(s) (2010). Quality assessment of patients’ self-monitoring of blood glucose in community pharmacies. Pharmacy Practice. 62-69.
  • Show author(s) (2010). Implementation of a method for glucose measurements in community pharmacies. International Journal of Pharmacy Practice (IJPP). 13-19.
  • Show author(s) (2010). Diagnosing microalbuminuria and consequences for the drug treatment of patients with type 2 diabetes: A European survey in primary care. Diabetes Research and Clinical Practice. 103-109.
  • Show author(s) (2009). Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thrombosis and Haemostasis. 593-600.
  • Show author(s) (2009). How to deal with semi-quantitative tests? Application of an ordinal scale model to measurements of urine glucose. Scandinavian Journal of Clinical and Laboratory Investigation. 662-U18.
  • Show author(s) (2009). Familial and sporadic porphyria cutanea tarda: Characterization and diagnostic strategies. Clinical Chemistry. 795-803.
  • Show author(s) (2008). Standardized Evaluation of Nine Instruments for Self-Monitoring of Blood Glucose. Diabetes Technology & Therapeutics. 467-477.
  • Show author(s) (2008). Postanalytical external quality assessment of urine albumin in primary health care: An international survey. Clinical Chemistry. 1630-1636.
  • Show author(s) (2008). Opinion Paper: 'Likelihood-ratio' and 'odds' applied to monitoring of patients as a supplement to 'reference change value' (RCV). Clinical Chemistry and Laboratory Medicine. 157-164.
  • Show author(s) (2008). How to deal with dichotomous tests? Application of a rankit ordinal scale model with examples from the Nordic ordinal scale project on screening tests. Scandinavian Journal of Clinical and Laboratory Investigation. 298-311.
  • Show author(s) (2008). Diabetes care in Norwegian pharmacies: a descriptive study. Pharmacy World & Science (PWS). 191-198.
  • Show author(s) (2006). Results and feasibility of an external quality assessment scheme for self-monitoring of blood glucose. Clinical Chemistry. 1311-1317.
  • Show author(s) (2006). Quality assessment of urine dip-slides in primary care. Tidsskrift for Den norske legeforening. 149-152.
  • Show author(s) (2006). Proficiency testing in analytical chemistry, microbiology and laboratory medicine - working group discussions on current status, problems and future directions. Accreditation and Quality Assurance. 446-450.
  • Show author(s) (2006). Postanalytical external quality assessment of warfarin monitoring in primary healthcare. Clinical Chemistry.
  • Show author(s) (2006). Postanalytical external quality assessment of warfarin monitoring in primary healthcare. Clinical Chemistry. 1871-1878.
  • Show author(s) (2006). External quality assessment of prothrombin time: The split-sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 337-349.
  • Show author(s) (2006). Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. Clinical Chemistry. 650-656.
  • Show author(s) (2006). Estimation and Application of Biological Variation of Urinary δ-Aminolevulinic Acid and Porphobilinogen in Healthy Individuals and in Patients with Acute Intermittent Porphyria. Clinical Chemistry. 650-656.
  • Show author(s) (2005). Postanalytical external quality assessment of blood glucose and hemoglobin A(1c): An international survey. Clinical Chemistry. 1145-1153.
  • Show author(s) (2005). Porphyrias, a challenge for diagnostic assessment and treatment. Clinical Laboratory International. 6-8.
  • Show author(s) (2005). Between-lot variation in external quality assessment of glucose: Clinical importance and effect on participant performance evaluation. Clinical Chemistry. 1632-1636.
  • Show author(s) (2004). Urine analysis and decision-making on cystitis in general practice. Scandinavian Journal of Clinical and Laboratory Investigation. 729-736.
  • Show author(s) (2004). Prostrate-specific antigen and prostate cancer: General practitioners' and urologists' use of evidence-based information. Tidsskrift for Den norske legeforening. 2893-2895.
  • Show author(s) (2004). Evidence-based guidelines in laboratory medicine: Principles and methods. Clinical Chemistry. 806-818.
  • Show author(s) (2004). Basic model and preliminary results on a Nordfond project on measurements reported on an ordinal scale. Klinisk Biokemi i Norden. 21-26.
  • Show author(s) (2003). Human reticulocytes isolated from peripheral blood: maturation time and hemoglobin synthesis. Laboratory Hematology. 198-206.
  • Show author(s) (2003). Health technology assessment and implications for clinical practice: The case of prostate cancer screening. Scandinavian Journal of Clinical and Laboratory Investigation. 331-338.
  • Show author(s) (2003). Evaluering av nye laboratorieanalyser. Tidsskrift for Den norske legeforening. 337-339.
  • Show author(s) (2002). Instruments for self-monitoring of blood-glucose: comparison of testing quality achieved by patients and a technician. Clinical Chemistry. 994-1003.
  • Show author(s) (2001). Analyse av protrombintid i primærhelsetjenesten. Tidsskrift for Den norske legeforening. 3435-3436.
  • Show author(s) (2000). Use and interpretation og HbA1c-testing in general practice. Implications for quality of care. Scandinavian Journal of Clinical and Laboratory Investigation. 349-356.
  • Show author(s) (2000). Use and interpretation og HbA1c-testing in general practice. Implications for quality of care. Scandinavian Journal of Clinical and Laboratory Investigation. 349-356.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Läkartidningen. 1754-1760.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Tidsskrift for Den norske legeforening. 1754-1760.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Läkartidningen. 4437-4448.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Tidsskrift for Den norske legeforening. 1754-1760.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av akutte vannlatingsplager hos kvinner. Tidsskrift for Den norske legeforening. 1748-1753.
  • Show author(s) (2000). Retningslinjer for diagnostikk og behandling av akutte vannlatingsplager hos kvinner. Tidsskrift for Den norske legeforening. 1748-1753.
  • Show author(s) (2000). Porphyrins and Porphyrias. Review and special articles from the Nordic countries. (Spesialnummer). Scandinavian Journal of Clinical and Laboratory Investigation. 508-648.
  • Show author(s) (2000). Porphyrins and Porphyrias. Review and special articles from the Nordic countries. (Spesialnummer). Scandinavian Journal of Clinical and Laboratory Investigation. 508-648.
  • Show author(s) (2000). Nodelling an estimation of measurement error. Statistics in Medicine. 146.
  • Show author(s) (2000). Nivået på dokumentasjonen og styrken på anbefalingene i kliniske retningslinjer. Tidsskrift for Den norske legeforening. 1791-1795.
  • Show author(s) (2000). Nivået på dokumentasjonen og styrken på anbefalingene i kliniske retningslinjer. Tidsskrift for Den norske legeforening. 1791-1795.
  • Show author(s) (2000). Kan laboratoriesvaret få konsekvenser for pasienten? Tidsskrift for Den norske legeforening. 2241.
  • Show author(s) (2000). Kan laboratoriesvaret få konsekvenser for pasienten? Tidsskrift for Den norske legeforening. 2241 pages.
  • Show author(s) (2000). Foster med hydrops hos kvinne fra Vietnam. Tidsskrift for Den norske legeforening. 1878-1881.
  • Show author(s) (2000). Foster med hydrops hos kvinne fra Vietnam. Tidsskrift for Den norske legeforening. 1878-1881.
  • Show author(s) (2000). Automated counting of white and red blood cells in the cerebrospinal fluid. Clinical and Laboratory Haematology. 203-210.
  • Show author(s) (2000). Automated counting of white and red blood cells in the cerebrospinal fluid. Clinical and Laboratory Haematology. 203-210.
  • Show author(s) (2000). A model for setting analytical quality specifications and design of control for measurements on the ordinal scale. Clinical Chemistry and Laboratory Medicine. 545-551.
  • Show author(s) (2000). A model for setting analytical quality specifications and design of control for measurements on the ordinal scale. Clinical Chemistry and Laboratory Medicine. 545-551.
  • Show author(s) (1999). The index of individuality is often a misinterpreted quantity characteristic. Clinical Chemistry and Laboratory Medicine. 655-661.
  • Show author(s) (1999). Skandinavisk utprøving av laboratorieutstyr for primærhelsetjenesten. Etablering av SKUP og igangsetting av de første evalueringene. Klinisk Biokemi i Norden. 56-60.
  • Show author(s) (1999). Quality specifications based upon objective analyses based upon clinical needs. Scandinavian Journal of Clinical and Laboratory Investigation.
  • Show author(s) (1999). Oppslagsbok i laboratoriemedisin. Tidsskrift for Den norske legeforening.
  • Show author(s) (1999). Measurement error and laboratory medicine. Statistics in Medicine.
  • Show author(s) (1999). External quality assurance of test requesting and test interpretations in general practice. A method for developing quality goals from clinicians' opinion and to implement guidelines. Labquality News. 13-14.
  • Show author(s) (1999). External quality assurance of test requesting and test interpretation. Accreditation and Quality Assurance. 414-415.
  • Show author(s) (1999). Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clinical Chemistry. 189-198.
  • Show author(s) (1999). Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clinical Chemistry. 189-198.
  • Show author(s) (1999). Circadian variations in human peripheral blood on days with and witout bone marrow sampling and relation to bone marroe cell proliferation. Biological rhythm research. 29-53.
  • Show author(s) (1999). Circadian variation in human peripheral blood on days with and without bone marrow sampling and relation to bone marrow proliferation. Biological rhythm research. 29-53.
  • Show author(s) (1999). Circadian Variations in Human Peripheral Blood on Days With and Without Bone Marrow Sampling and Relation to Bone Marrow Cell Proliferation. Biological rhythm research. 29-53.
  • Show author(s) (1999). Bruk og tolking av serum-kalsiumanalyse. Tidsskrift for Den norske legeforening. 3299.
  • Show author(s) (1998). Resultater fra NOKLUS' utsendelser 1993-97. Tidsskrift for Den norske legeforening. 1196-1200.
  • Show author(s) (1997). Use and usefulnes of laboratory handbooks. Scandinavian Journal of Clinical and Laboratory Investigation. 647-654.
  • Show author(s) (1997). Use and usefulnes of laboratory handbooks. Scandinavian Journal of Clinical and Laboratory Investigation. 647-654.
  • Show author(s) (1997). Use and usefullness of laboratory handbooks. Scandinavian Journal of Clinical and Laboratory Investigation. 647-654.
  • Show author(s) (1997). Systematic reviews of diagnostic tests - a new challenge for laboratory medicine. Scandinavian Journal of Clinical and Laboratory Investigation. 369-372.
  • Show author(s) (1997). Systematic reviews of diagnostic tests - a new challenge for laboratory medicine. Scandinavian Journal of Clinical and Laboratory Investigation. 369-372.
  • Show author(s) (1997). Systematic reviewing in laboratory medicine. JIFCC. 154-155.
  • Show author(s) (1997). Systematic review of diagnostic tests. Nordic newsletter on evidence-based health care. 5-5.
  • Show author(s) (1997). Systematic review of diagnostic tests. Nordic newsletter on evidence-based health care. 5.
  • Show author(s) (1997). SKUP - Skandinavisk samarbeid om utprøving av laboratorieutstyr for primærhelsetjenesten. Klinisk Biokemi i Norden. 49-52.
  • Show author(s) (1997). SKUP - Skandinavisk samarbeid om utprøving av laboratorieutstyr for primærhelsetjenesten. Klinisk Biokemi i Norden. 49-52.
  • Show author(s) (1997). Etablering av referanseverdier. Bioingeniøren. 5-7.
  • Show author(s) (1997). Etablering av referanseverdier. Bioingeniøren. 5-7.
  • Show author(s) (1996). Erythropoietic, protoporphyria: two populations of reticulocytes, with and without protoporphyrin. European Journal of Clinical Investigation. 270-8.
  • Show author(s) (1996). Analysekvalitet av hemoglobin og glukose i allmennpraksis. Tidsskrift for Den norske legeforening. 25-9.
  • Show author(s) (1995). Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-390.
  • Show author(s) (1995). Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-390.
  • Show author(s) (1995). Circadian phase relationship between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-89.
Academic lecture
  • Show author(s) (2017). Type 2 diabetes in General Practice in Norway 2005-2014: Moderate improvements in risk Control but still major gaps in complication screening.
  • Show author(s) (2007). Control of patients' glucometers and SMBG technique in community pharmacies.
  • Show author(s) (2006). How to deal with qualitative tests? Principles.
  • Show author(s) (2004). Hvordan bruker legene urinstrimmelen til diagnostikk av UVI?
Abstract
  • Show author(s) (2014). POC testing instruments for diagnosing and monitoring diabetes in clinical settings. Biochemia Medica. S39-S40.
  • Show author(s) (2013). Searching for pharmacological chaperones aiding to stabilize hydroxymethylbilane synthase. The FEBS Journal. 298-298.
  • Show author(s) (2011). Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in minors. British Journal of Dermatology. 1133-1134.
  • Show author(s) (2011). POST-ANALYTICAL EXTERNAL QUALITY ASSESSMENT - A WAY TO ASSESS TEST REQUESTING AND INTERPRETATION. Clinical Chemistry and Laboratory Medicine. S111-S111.
  • Show author(s) (2011). Optimizing porphyria diagnostics with emphasis on pre-analytical, analytical and postanalytical aspects S. Sandberg on behalf of EPNET. British Journal of Dermatology. 1129-1129.
  • Show author(s) (2010). Characterization of the molecular basis of acute intermittent porphyria. The FEBS Journal. 76-76.
  • Show author(s) (2010). CHARACTERIZATION OF THE MOLECULAR BASIS OF ACUTE INTERMITTENT PORPHYRIA. The Journal of Inherited Metabolic Disease (JIMD). S177-S177.
  • Show author(s) (2005). External quality assessments of whole blood prothrombin time: Comparison of two methods. Clinica Chimica Acta.
  • Show author(s) (2005). Can we interpret laboratory results correctly? Clinica Chimica Acta.
  • Show author(s) (2005). Between lot variation in external quality assessment of glucose: Clinical importance and effect on the evaluation of participants' performance. Clinica Chimica Acta.
Academic literature review
  • Show author(s) (2023). Analytical performance specifications and quality assurance of point-of-care testing in primary healthcare. Critical reviews in clinical laboratory sciences.
  • Show author(s) (2022). Personalized reference intervals: from theory to practice. Critical reviews in clinical laboratory sciences. 506-516.
  • Show author(s) (2022). Critical review and meta-analysis of biological variation estimates for tumor markers. Clinical Chemistry and Laboratory Medicine. 494-504.
  • Show author(s) (2022). Biological variation: recent development and future challenges. Clinical Chemistry and Laboratory Medicine.
  • Show author(s) (2021). The European Biological Variation Study (EuBIVAS): A summary report. Clinical Chemistry and Laboratory Medicine. 1-13.
  • Show author(s) (2021). Setting analytical performance specifications using HbA1c as a model measurand. Clinica Chimica Acta. 407-414.
  • Show author(s) (2021). Biological variation of cardiac troponins in health and disease: A systematic review and meta-analysis. Clinical Chemistry. 256-264.
  • Show author(s) (2021). Acute intermittent porphyria: An overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators. International Journal of Molecular Sciences. 25 pages.
  • Show author(s) (2020). Critical evaluation and meta-analysis of biological variation studies for glycosylated albumin, glucose and HbA<inf>1c</inf>. Advances in laboratory medicine.
  • Show author(s) (2020). Critical appraisal and meta-analysis of biological variation estimates for kidney related analytes. Clinical Chemistry and Laboratory Medicine. 1-10.
  • Show author(s) (2019). Systematic review of the biological variation data for diabetes related analytes. Clinica Chimica Acta. 61-67.
  • Show author(s) (2019). Systematic review and meta-analysis of within-subject and between-subject biological variation estimates of 20 haematological parameters. Clinical Chemistry and Laboratory Medicine. 25-32.
  • Show author(s) (2019). Biological variation data for lipid cardiovascular risk assessment biomarkers. A systematic review applying the biological variation data critical appraisal checklist (BIVAC). Clinica Chimica Acta. 467-475.
  • Show author(s) (2017). Essential aspects of external quality assurance for point-of-care testing. Biochemia Medica. 81-85.
  • Show author(s) (2017). Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference. Clinical Chemistry and Laboratory Medicine. 189-194.
  • Show author(s) (2014). How to conduct External Quality Assessment Schemes for the pre-analytical phase? Biochemia Medica. 114-122.
  • Show author(s) (2013). Glucose meters - fit for clinical purpose. Clinical Chemistry and Laboratory Medicine. 943-952.
  • Show author(s) (2012). Self-monitoring of blood glucose in patients with diabetes who do not use insulinuare guidelines evidence-based? Diabetic Medicine. 1226-1236.
  • Show author(s) (2010). Self-monitoring of blood glucose with a focus on analytical quality: an overview. Clinical Chemistry and Laboratory Medicine. 963-972.
  • Show author(s) (2009). Evaluation of prescription and interpretation of microalbuminuria by general practitioners. Annales de Biologie Clinique. 47-53.
  • Show author(s) (2009). Current Issues in Measurement and Reporting of Urinary Albumin Excretion. Clinical Chemistry. 24-38.

More information in national current research information system (CRIStin)